TheBodyPro: Expert analysis from Benjamin Young, M.D., Ph.D.
For HIV-treating clinicians of a certain age, the term “lipodystrophy” probably conjures a complex mish-mash of memories: atypically large abdomens and necks; atypically thin limbs, buttocks, and faces; and a significant amount of frustration and confusion among patients during a time when antiretroviral therapy was otherwise working immunological miracles.
In some very significant ways, we are treating a very different HIV epidemic these days than we were back then. But as a new study out of Washington, D.C., informs us, lipodystrophy remains a real and present issue among our patients today — both as a legacy matter and as a still-emerging concern with a significant impact on other comorbidity risks.
Read the full analysis here.
Source : TheBodyPro
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.